Spinal Cord Injury Trials Vocabulary – Acronym Chart

This information was compiled for the benefit of the spinal cord injury community and will be updated regularly. Note the 3 tabs at the bottom to access information on Ongoing and Completed Trials. The CSRO/ASRO does not imply or infer an endorsement or recommendation of the below mentioned research.

ABT Activity Based Therapy
ADSC Adipose Derived Stem Cells (Body Fat)
ahSC Autologous Human Schwann Cells
AIS American Spinal Injury Association Impairment Scale (AIS): International Standards for Neurological Classification of Spinal Cord Injury
ALS Amyotrophic Lateral Sclerosis
BMSC Bone Marrow Stromal or Stem Cell
BMMNC Bone Marrow Mononuclear Cell
BMPC Bone Marrow Progenitor Cells
BMI Brain Machine Interface
CPG Central Pattern Generator
DOD Department of Defense (US)
DTI Diffusion Tensor Imaging
ECoG Electrocorticography
EMG Electromyographic
FES Functional Electrical Stimulation
FGF Fibroblast Growth Factor
FDA Food & Drug Administration
GRNOPC1 Geron Oligodendrocyte Progenitor Cell
hESC Human Embryonic Stem Cell
hOESC Human Olfactory Ensheathing Stem Cell
HUCB-MNC Human Umbilical Cord Blood Mononuclear Cells
HNSC Human Neural Stem Cell
HSSC Human Spinal Cord Stem Cell
IDE Investigational Device Exemption
IND Investigational New Drug
iPSC Induced Pluripotent Stem Cell
MSC Mesenchymal Stem Cell
NIH National Institutes of Health
OLP Olfactory Lamina Propria
OPC Oligodendrocyte Progenitor Cells
PI Principal Investigator
rhHGF Recombinant Human Hepatocyte Growth Factor
SCI Spinal Cord Injury
SMA Spinal Muscular Atrophy
TMS Transcranial Magnetic Stimulation
UC-MSC Human Umbilical Cord-derived Mesenchymal Stem Cells